Episode 294: ASCO GU 2024: Adjuvant Pembrolizumab in Bladder Cancer

Release Date:

Andrea Apolo describes the results of this positive trial.

Episode 294: ASCO GU 2024: Adjuvant Pembrolizumab in Bladder Cancer

Title
Episode 294: ASCO GU 2024: Adjuvant Pembrolizumab in Bladder Cancer
Copyright
Release Date

flashback